주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-25 16:53 (Thurs)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Reporter’s Notebook
목록
(
총 :
19 )
기사목록 보기 형태
제목형
요약형
포토형
[Reporter's Notebook] The abandoned Hanmi-OCI merger shows the power of the small shareholders
Lee Han-soo
2024.03.29 13:20
[Reporter's Notebook] Is lawmaker's claim that Celltrion's Covid-19 drug was a failure true?
Lee Han-soo
2023.10.12 13:06
[Reporter's Notebook] Korean companies bet on Cancer Moonshot but uncertainty looms
Lee Han-soo
2023.09.01 15:49
[Reporter's Notebook] GemVax & KAEL's 'miracle cure' for Alzheimer's disease needs scrutiny
Lee Han-soo
2023.07.19 11:34
[Reporter's Notebook] Is ‘special listing’ system hurting biotech industry?
Lee Han-soo
2023.04.13 17:28
[Reporter's notebook] Cheering for Lilly Korea’s bid
Kim Yun-mi
2023.03.09 15:32
Mundipharma Korea, a ‘good place to work,’ suspends employees refusing ERP
Jeong Min-jun
2023.03.07 15:26
[Reporter's Notebook] Lost are the government's bio-industry promotion policies for 2023
Kim Chan-hyuk
2023.01.31 16:16
Korean biopharma shouldn’t make promises if they can’t keep them
Lee Han-soo
2022.11.02 13:55
Global Bio Conference, not ‘global’ at all
Lee Han-soo
2022.09.08 14:43
[Reporter’s Notebook] Why does Janssen need a PR department – or an offshoot -- in Korea?
Lee Han-soo
2022.04.12 16:47
[Reporter’s Notebook] Rival candidates ‘politicize’ foreign residents’ health insurance issue
Lee Han-soo
2022.02.03 17:32
처음
1
2
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기